THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 118 filers reported holding THERAVANCE BIOPHARMA INC in Q4 2021. The put-call ratio across all filers is 7.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $929,865 | -26.2% | 107,748 | -11.4% | 0.01% | -40.0% |
| Q2 2023 | $1,259,243 | +106706.0% | 121,666 | +12.0% | 0.02% | -16.7% |
| Q1 2023 | $1,179 | +12.5% | 108,635 | +16.3% | 0.02% | -14.3% |
| Q4 2022 | $1,048 | -99.9% | 93,434 | -9.5% | 0.02% | -16.0% |
| Q2 2022 | $936,000 | +206.9% | 103,280 | +223.6% | 0.02% | +257.1% |
| Q1 2022 | $305,000 | -84.1% | 31,916 | -81.6% | 0.01% | -78.1% |
| Q4 2021 | $1,916,000 | +400.3% | 173,414 | +235.4% | 0.03% | +433.3% |
| Q3 2021 | $383,000 | +5.8% | 51,709 | +86.0% | 0.01% | -45.5% |
| Q2 2015 | $362,000 | – | 27,800 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Link Fund Solutions Ltd | 5,251,349 | $135,459,000 | 69.86% |
| Chescapmanager LLC | 949,006 | $24,570,000 | 3.61% |
| Baupost Group | 9,309,168 | $241,014,000 | 2.66% |
| Rock Springs Capital Management LP | 655,200 | $16,963,000 | 0.54% |
| Rubric Capital Management LP | 173,400 | $4,489,000 | 0.51% |
| Newtyn Management, LLC | 173,300 | $4,487,000 | 0.41% |
| NJ State Employees Deferred Compensation Plan | 38,142 | $988,000 | 0.17% |
| King Wealth Management Group | 22,500 | $583,000 | 0.15% |
| Virtus ETF Advisers LLC | 29,216 | $756,000 | 0.12% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 452,615 | $11,718,000 | 0.12% |